Form
SCHEDULE 13D
Active or control-oriented beneficial ownership filing.
Kaupinen Wes - 13 Dec 2024 SCHEDULE 13D Report for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA)
- Large-stake signal
-
Ownership
15%Beneficial ownership of this reported class.
Shares
1,644,869 sharesShares beneficially owned as disclosed.
Event date
13 Dec 2024Date tied to the ownership event or amendment.
Accepted by SEC
20 Dec 2024EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 15%
- Symbol
- PVLA
- Shares outstanding
- 11,266,226 shares
- SEC form
- SCHEDULE 13D
- Accepted by SEC
- 20 Dec 2024, 17:32:09 UTC
- Event date
- 13 Dec 2024
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Kaupinen Wes disclosed 15% ownership in PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA) on 13 Dec 2024.
Key facts
- Kaupinen Wes filed SCHEDULE 13D for PALVELLA THERAPEUTICS, INC. Common Stock, $0.001 par value per share (PVLA).
- Disclosed ownership: 15%.
- Date of event: 13 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Dec 2024, 17:32.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kaupinen Wes | 15% | 1,644,869 | 82,051 | 1,562,818 | Wesley H. Kaupinen | Wesley H. Kaupinen | 0001918142 |
| Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | 781,409 | 0 | 781,409 | Christine L. Kaupinen | Trustee | |
| Christine L. Kaupinen | 14% | 1,562,818 | 0 | 1,562,818 | Christine L. Kaupinen | Christine L. Kaupinen | |
| Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | 781,409 | 0 | 781,409 | Michael Christopher | Trustee | |
| Michael Christopher | 6.9% | 781,409 | 0 | 781,409 | Michael Christopher | Michael Christopher |
CIK / CUSIP context first